| 1 |
32568218 | Induction and Characterization of Pulmonary Hypertension in Mice using the Hypoxia/SU5416 Model. | 2020 Jun 3 |
2 |
| 2 |
31208454 | SU5416 does not attenuate early RV angiogenesis in the murine chronic hypoxia PH model. | 2019 Jun 17 |
2 |
| 3 |
31213766 | SU5416 attenuated lipopolysaccharide-induced acute lung injury in mice by modulating properties of vascular endothelial cells. | 2019 |
2 |
| 4 |
28358962 | VEGF as a Paracrine Regulator of Conventional Outflow Facility. | 2017 Mar 1 |
1 |
| 5 |
26727223 | VEGF/VEGFR2 Signaling Regulates Germ Cell Proliferation in vitro and Promotes Mouse Testicular Regeneration in vivo. | 2016 |
1 |
| 6 |
26938051 | ACE2 Antagonizes VEGFa to Reduce Vascular Permeability During Acute Lung Injury. | 2016 |
1 |
| 7 |
24257464 | Hypoxic stress, brain vascular system, and β-amyloid: a primary cell culture study. | 2015 Jan |
1 |
| 8 |
25521760 | Prostatic angiogenic responses in late life: antiangiogenic therapy influences and relation with the glandular microenvironment in the transgenic adenocarcinoma of mouse prostate (TRAMP) model. | 2015 Apr 1 |
1 |
| 9 |
24985750 | Determinants for in vivo antitumor effect of angiogenesis inhibitor SU5416 formulated in PEGylated emulsion. | 2014 Aug |
2 |
| 10 |
25009649 | Alcohol promotes mammary tumor growth through activation of VEGF-dependent tumor angiogenesis. | 2014 Aug |
1 |
| 11 |
21691137 | Inhibitory effects of SU5416, a selective vascular endothelial growth factor receptor tyrosine kinase inhibitor, on experimental corneal neovascularization. | 2012 |
1 |
| 12 |
22412930 | Normalization of the lymph node T cell stromal microenvironment in lpr/lpr mice is associated with SU5416-induced reduction in autoantibodies. | 2012 |
1 |
| 13 |
22096367 | Effects of SU5416 and a vascular endothelial growth factor neutralizing antibody on wear debris-induced inflammatory osteolysis in a mouse model. | 2011 |
1 |
| 14 |
19766642 | ERK1/2-dependent vascular endothelial growth factor signaling sustains cyst growth in polycystin-2 defective mice. | 2010 Jan |
1 |
| 15 |
20145550 | Tumor secretion of VEGF induces endothelial cells to suppress T cell functions through the production of PGE2. | 2010 Feb-Mar |
2 |
| 16 |
20415720 | A viral PAMP double-stranded RNA induces allergen-specific Th17 cell response in the airways which is dependent on VEGF and IL-6. | 2010 Oct |
1 |
| 17 |
18976720 | VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice. | 2009 Jan |
1 |
| 18 |
19242105 | Oral administration of pyrrolidine dithiocarbamate (PDTC) inhibits VEGF expression, tumor angiogenesis, and growth of breast cancer in female mice. | 2009 Mar 15 |
1 |
| 19 |
18626731 | Inhibition of choroidal neovascularization by blocking vascular endothelial growth factor receptor tyrosine kinase. | 2008 Mar-Apr |
1 |
| 20 |
16428272 | Pleiotropic role of VEGF-A in regulating fetal pulmonary mesenchymal cell turnover. | 2006 Jun |
1 |
| 21 |
16988063 | Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice. | 2006 Nov |
2 |
| 22 |
15840669 | Angiotensin II stimulates alpha3(IV) collagen production in mouse podocytes via TGF-beta and VEGF signalling: implications for diabetic glomerulopathy. | 2005 Jul |
2 |
| 23 |
15078481 | Liver regeneration in FGF-2-deficient mice: VEGF acts as potential functional substitute for FGF-2. | 2004 Apr |
1 |
| 24 |
15155530 | Vascular endothelial growth factor overexpression in ischemic skeletal muscle enhances myoglobin expression in vivo. | 2004 Jul 9 |
1 |
| 25 |
15504975 | Podocyte-derived vascular endothelial growth factor mediates the stimulation of alpha3(IV) collagen production by transforming growth factor-beta1 in mouse podocytes. | 2004 Nov |
2 |
| 26 |
12611597 | Effect of angiogenesis inhibitors on oestrogen-mediated endometrial endothelial cell proliferation in the ovariectomized mouse. | 2003 Mar |
2 |
| 27 |
11754641 | The antiangiogenic agents SU5416 and SU6668 increase the antitumor effects of fractionated irradiation. | 2002 Jan |
2 |
| 28 |
11969307 | Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis. | 2002 May |
3 |
| 29 |
12069500 | Vascular endothelial growth factor-mediated angiogenesis inhibition and postoperative wound healing in rats. | 2002 Jun 1 |
2 |
| 30 |
11280761 | Vascular endothelial growth factor effects on nuclear factor-kappaB activation in hematopoietic progenitor cells. | 2001 Mar 1 |
3 |
| 31 |
10804086 | Measuring VEGF-Flk-1 activity and consequences of VEGF-Flk-1 targeting in vivo using intravital microscopy: clinical applications. | 2000 |
1 |
| 32 |
10861485 | Targeting angiogenesis inhibits tumor infiltration and expression of the pro-invasive protein SPARC. | 2000 Jul 15 |
1 |
| 33 |
11025665 | Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. | 2000 Oct |
1 |
| 34 |
11122336 | Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor. | 2000 Dec |
1 |